Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-11-12, Stock:LLY, The news for the past five days is as follows:
2020-11-05: NEWS1: Celltrion Reports Positive Results for COVID-19 antibody CT-P59.NEWS2: Incyte Earnings Miss Expectations; Tightens Outlook For Top Product.NEWS3: Q3 Earnings Fail to Impress Pharma ETFs.NEWS4: Incyte Earnings Miss Expectations; Tightens Outlook For Top Product.NEWS5: Incyte (INCY) Q3 Earnings & Sales Miss, Jakafi Demand Strong.NEWS6: Loxo Oncology at Lilly Announces Details of LOXO-305 Presentations at the 2020 American Society of Hematology (ASH) Annual Meeting.NEWS7: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of Eli Lilly and Company - LLY.NEWS8: Analyst Report: Eli Lilly and Company.
2020-11-06: NEWS1: Former Vanguard Group CEO Bill McNabb Bought Up IBM Stock.NEWS2: Elanco Animal Health Stock Stumbles After Earnings Report.
2020-11-09: NEWS1: Lilly's neutralizing antibody bamlanivimab (LY-CoV555) receives FDA emergency use authorization for the treatment of recently diagnosed COVID-19.NEWS2: Price Over Earnings Overview: Eli Lilly.
2020-11-10: NEWS1: 'We're in a critical period right now': Infectious Disease Physician on current state of COVID-19 in the U.S..NEWS2: 'It would be devastating': Former Obama advisor Valerie Jarrett on possibility of the Supreme Court overturning the Affordable Care Act.NEWS3: Why Eli Lilly's Coronavirus Drug Authorization Is Bad News For A Key Rival.NEWS4: Stock Market Today: Growth Takes a Backseat to Value Yet Again.NEWS5: Jim Cramer on the Search for Stock-Buying Opportunities Tuesday.NEWS6: Doctor: Vaccine availability will be a 'valuable asset in this fight against COVID-19'.NEWS7: U.S. to start distributing Lilly COVID-19 antibody this week.NEWS8: Dow Jones Leads Mixed Market As Covid Vaccine Hopes Slam Tech Stocks Again.NEWS9: Coronavirus updates: Efficacy concerns; Biden backs masks.NEWS10: Reopening Stocks Gain on Vaccine Hopes.NEWS11: New Covid Treatments Are Here, But Who Gets Them?.NEWS12: Blue Chips & Tech Going Separate Directions: PFE, GOOGL, FB, LLY & More.NEWS13: Jim Cramer on Markets, COVID-19 Rally, Eli Lilly, McDonald's, Apple, Beyond Meat: LIVE.NEWS14: Despite vaccine progress, ‘economic data can get worse before it gets better’, says strategist.NEWS15: Return On Capital Employed Overview: Eli Lilly.NEWS16: Dow Futures Mixed, Nasdaq Slides, As Pfizer Vaccine Breakthrough Prompts Market Re-Set.NEWS17: The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies.NEWS18: Dow Rises as Tech Loses Luster Amid Get Away from Home Hopes.NEWS19: Some States Announce New Restrictions as U.S. Passes 10 Million Covid Cases.NEWS20: Eli Lilly COVID Treatment Wins Emergency FDA Clearance.NEWS21: Eli Lilly, Covid-19 Vaccine, Beyond Meat, Lyft - 5 Things You Must Know Tuesday.NEWS22: Eli Lilly’s Covid-19 Antibody Treatment Gets FDA Emergency Use Nod.NEWS23: U.S. Futures Mixed; Nasdaq Drops 169 Pts with Tech Out of Favor.NEWS24: Eli Lilly's Antibody Treatment For COVID-19 Gets FDA Emergency Use Authorization.NEWS25: Eli Lilly's COVID-19 Treatment Authorized by the FDA.NEWS26: Lilly COVID Treatment Wins Emergency FDA Clearance.NEWS27: Lilly’s COVID-19 treatment receives emergency-use approval from FDA, stock jumps 3%.
2020-11-11: NEWS1: Lilly Announces Webcast to Provide an Overview of Tirzepatide Phase 3 clinical program.NEWS2: Vaccine Hopes Rise as Pharma Giants Inch Closer Toward Success.

Answer: Decrease